ABSTRACT
Introduction
Anal squamous cell carcinomas (ASCC) are 20 to 30 times less frequent than colorectal carcinomas 1 . According to their location, they can be divided into anal canal tumors, present in 85% of such patients, and those of the anal verge, which are similar to skin carcinomas 2 .
ASCC most frequently affects women in their sixties, in proportions of 5:1 in relation to men 3, 4 . However, a change in this epidemiological profile has been taken place since the onset of the AIDS epidemics. The incidence of this kind of tumor has increased among HIV-infected men aged 30 to 40 years who practice anal receptive sex 5, 6 . In this group of patients, ASCC is 25 to 50 times more frequent than among HIV-negative men of the same age 7 , thus suggesting that immunological suppression and HIV infection are important in carcinogenesis.
ASCC appears to be associated with human papillomavirus (HPV) infection 8 , which induces dysplasia in the anal mucosa of anal sex practitioners [9] [10] [11] . These anal dysplasias are nowadays named anal intraepithelial neoplasia (AIN) and may be low-grade (LAIN) or high-grade (HAIN) 12, 13 . They are most common among HIV-infected individuals 14, 15 , even during highly active antiretroviral therapy (HAART) 16 . Although such treatment improves systemic immunity, apparently it does not influence local immunity in patients with an incomplete response 17, 18 .
Langerhans cells (LCs), which are located in the suprabasal portion of the epidermis, are the immature dendritic cells of the cutaneous immune system. They capture antigens that enter through the skin and, by stimulating proinflammatory cytokines, lose their adherence to epidermal cells and migrate to the regional lymph nodes through lymphatic vessels. Activated
LCs are stable and become resistant to tumor-related suppressor factors, and they show an increasing ability to induce an immune response 5 . Immunodeficiency decreases the LC population and prevents their immediate activation 4 . By provoking local immunosuppression, HIV causes a defective immune response to virus infection, thereby explaining the increased rates of dysplasia and cancer in these patients' anogenital region 19 . Furthermore, inhibition of LC migration caused by tumor-derived factors prevents LCs from promoting anti-tumoral immunity 20 .
Several studies have shown low density of LCs in SCC of the skin 21 , uterine cervix 22 and anal mucosa 23 , and recent research on cervical SCC has suggested that the decreased density of LCs is secondary to low E-cadherin expression 21 . On the other hand, HPV increases the number of LCs in the anal mucosa of HIV-negative individuals 24 . 25 . We studied The results were compared and subjected to statistical analysis using the non-parametric Mann Whitney test. Results were taken to be significant when p<0.05. Box plots were created using the SPSS software, release 9.0, in order to compare the sample graphically.
Results
The Group A had an average age of 57 years ranging The comparison between distributions of the control HIV-negative group and Group B can be seen in Figure 2 , and indicates that the Group B sample was below the 50 th percentile in relation to the HIV-negative control group, and its lower limit was zero. The maximum value for patient distribution in Group B was lower than the median value of the control HIV-negative group, and its median value was close to zero. The Mann Whitney test confirmed this difference between the two groups (p = 0.002). Figure 3 shows the comparison of LC counts between control HIV-positive group and Group B. The Group B sample was lower than the median value of the control HIV-positive group, and its median value was close to zero. The Mann Whitney test showed no difference between these distributions (p = 0.0219). There was no intersection areas, thus meaning that they were different, except for the outlying values of Group A. Active LC counts in these two groups were compared using the same nonparametric test as above, which showed a statistical difference (p = 0.002).
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FIGURE 5 -Boxplot -Comparison between Langerhans cells populations between Groups A and B.
Discussion
The change in the epidemiological profile of ASCC patients seem to be related to HIV infection and immunosuppression 2, 26 .
This can be seen from the fact that, whereas this tumor usually occurs in women 29, 30 , it presents increased frequency among HIVinfected men who have sex with men (MSM) 2 . Our study also shows this, since ASCC appeared among HIV-positive MSM who were younger than the HIV-negative women that we treated.
Nonetheless, if HPV is confirmed as an etiological agent for ASCC, this tumor can be considered to be a sexually transmitted disease 2, 31 . We did not include the viral types of our patients' tumors because this would not change the results or conclusions presented in this study.
We chose to include only anal canal SCC patients in AJCC stage II and IIIB, in an attempt to use groups that were as homogeneous as possible. We also excluded individuals with anal margin SCC, because the behavior of this kind of cancer is similar to that of cutaneous SCC.
We included the controls groups in order to ascertain what the LC population in the anal mucosa would be in a population that was as close as possible to normality, in order to make comparisons with the results from the ASCC patients. We used part of the anal mucosa from hemorrhoidectomy specimens from HIV-negative and positive patients, in order to avoid taking biopsies from volunteers with no anal diseases. The average LC count for the HIV-negative controls was 1.38 per site, which is similar to what has been reported in the literature 24 . We included a control group of HIV-infected people without HPV infection and there was no difference between the controls groups.
LCs are the main antigen-presenting cells in skin, and they function as a defense mechanism against infections and tumors such as these. We decided to study them in order to evaluate local immunity. We used anti-CD1A antibody staining because it provides a better view of active LCs than other molecules 32 . We chose to use the immunohistochemical technique described by Hsu 33 , which facilitates antigen identification in sections stained by CD1A.
We observed that the median sample in HIV-negative patients with ASCC was a little higher than in the control HIV- HIV-positive patients are believed to have more LCs that are infected with HIV. Thus, activation and migration to the local lymph nodes are inhibited, because they do not receive the proper chemokine signal for migration 37 , thus worsening local immune response 38 and resulting in persistent HPV infection, with an increased risk of neoplasia 37, 39 .
However, there may be several reasons why the immune system is unable to eradicate tumor cells 40 . Firstly, most tumors are derived from host cells and resemble normal tissues, expressing a few antigens that cannot be recognized and are consequently only weakly immunogenic. Secondly, the rapid growth and spread of tumors may overwhelm the capacity of the immune system to eradicate tumor cells. Thirdly, many tumors have specialized mechanisms for evading host immune responses 40 .
There is still much to learn about the activation mechanism of LCs. However, its regulation is directly related to immunity 41 . Tumor evolution is believed to inhibit the action of Furthermore, it may be inferred that there is a decrease in local immunity among HIV-positive patients.
